Results 251 to 260 of about 296,123 (303)

Drug‐coated balloons: From conventional designs to next‐generation innovations in vascular therapy

open access: yesBMEMat, EarlyView.
This review traces the evolution of drug‐coated balloons (DCBs) from conventional designs to next‐generation platforms. We highlight innovations in balloon engineering, coating technologies, and therapeutic agents that enhance localized drug delivery while addressing challenges in efficiency, safety, and biocompatibility for vascular and emerging non ...
Lu Zhang   +5 more
wiley   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

open access: yesBMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo   +9 more
wiley   +1 more source

Esophageal Cancer Patient Network: a scalable platform for integrating patient voices across the research lifecycle. [PDF]

open access: yesDis Esophagus
Trottenberg T   +9 more
europepmc   +1 more source

ERS Congress 2025: highlights from the Thoracic Surgery and Lung Transplantation Assembly. [PDF]

open access: yesERJ Open Res
Revilla-Lopez E   +7 more
europepmc   +1 more source

THORACIC DISEASE IN THE IMMUNOCOMPROMISED PATIENT

Radiologic Clinics of North America, 1992
Thoracic disease in the HIV negative immunocompromised host is most frequently caused by infection. Patterns of involvement produced on the chest radiograph include (1) lobar or segmental consolidation, (2) nodules with rapid growth and/or cavitation, and (3) diffuse lung disease.
T C, McLoud, D P, Naidich
openaire   +2 more sources

Home - About - Disclaimer - Privacy